Danyelza
Payments companies reported to CMS as associated with Danyelza. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Danyelza, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Danyelza
These are the largest totals companies reported as associated with Danyelza. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Evgeniya Angelova | Red Bank, NJ | Anatomic Pathology & Clinical Pathology | $98,400.00 |
| Steven Larson | New York, NY | Nuclear Medicine | $82,785.00 |
| Nai-Kong Cheung | New York, NY | Pediatric Hematology-Oncology | $80,000.00 |
| Hatice Gur | Boston, MA | Anatomic Pathology | $70,400.00 |
| Matthew Fletcher | Dallas, TX | Pediatric Hematology-Oncology | $23,004.44 |
| Jacqueline Kraveka | Charleston, SC | Pediatric Hematology-Oncology | $15,481.77 |
| Anurag Agrawal | Oakland, CA | Pediatric Hematology-Oncology | $10,329.00 |
| Roland Chu | Detroit, MI | Pediatric Hematology-Oncology | $9,562.93 |
| Leonora Slatnick | Aurora, CO | Pediatric Hematology-Oncology | $9,163.47 |
| Michael Eckrich | Madison, WI | Pediatric Hematology-Oncology | $5,279.11 |
Prescribed Danyelza?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.